Edition:
United States

Bellerophon Therapeutics Inc (BLPH.OQ)

BLPH.OQ on NASDAQ Stock Exchange Global Market

1.18USD
4:00pm EDT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.18
Open
$1.20
Day's High
$1.20
Day's Low
$1.13
Volume
128,468
Avg. Vol
114,473
52-wk High
$3.30
52-wk Low
$0.47

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.200
Mar '18 0.00 0.057
FY 2017 Dec '17 0.00 -0.437
Sep '17 0.00 -0.217
Jun '17 0.00 -0.117
Mar '17 0.00 -0.599
FY 2016 Dec '16 0.00 -0.367
Sep '16 0.00 -0.303
Jun '16 0.00 -0.392
Mar '16 0.00 -0.541
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 1 0.00 0.00 0.00 --
Quarter Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-18 1 -0.12 -0.12 -0.12 --
Quarter Ending Dec-18 1 -0.13 -0.13 -0.13 --
Year Ending Dec-18 1 -0.40 -0.40 -0.40 -0.98
Year Ending Dec-19 1 -0.54 -0.54 -0.54 -1.17
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 103.50 32.14
P/E High - Last 5 Yrs. -- 275.43 47.40
P/E Low - Last 5 Yrs. -- 97.43 24.78
Beta -0.98 0.62 0.87
Price to Sales (TTM) -- 109.71 6.23
Price to Book (MRQ) -- 12.03 3.80
Price to Tangible Book (MRQ) -- 18.41 5.78
Price to Cash Flow (TTM) -- 59.58 22.50
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.73
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.55 -5.60
Payout Ratio(TTM) -- 5.86 46.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 174.85 8.41
Sales (TTM) vs TTM 1 Yr. Ago -- 91.86 6.69
Sales - 5 Yr. Growth Rate -- 24.26 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago -71.20 272.94 25.39
EPS (TTM) vs TTM 1 Yr. Ago 42.48 -- --
EPS - 5 Yr. Growth Rate -- 23.39 7.57
Capital Spending - 5 Yr. Growth Rate -- 38.46 8.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.61 2.18
Current Ratio (MRQ) 3.19 5.48 2.95
LT Debt to Equity (MRQ) -- 14.97 11.33
Total Debt to Equity (MRQ) -- 18.40 14.17
Interest Coverage (TTM) -1.81 -204.17 34.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.80 54.77
Gross Margin - 5 Yr. Avg. -- 52.46 53.26
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -175.51 15.90
Operating Margin (TTM) -- -608.67 3.68
Operating Margin - 5 Yr. Avg. -- -189.07 11.01
Pre-Tax Margin (TTM) -- -605.68 3.97
Pre-Tax Margin - 5 Yr. Avg. -- -191.53 11.18
Net Profit Margin (TTM) -- -601.23 0.71
Net Profit Margin - 5 Yr. Avg. -- -189.32 7.52
Effective Tax Rate (TTM) -- 11.41 20.36
Effective Tax Rate - 5 Yr. Avg. -- 18.93 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 5,162,908 710,435,462
Net Income/Employee (TTM) -- -6,026,407 81,903,466
Receivable Turnover (TTM) -- 5.43 5.02
Inventory Turnover (TTM) -- 2.04 3.62
Asset Turnover (TTM) 0.00 0.37 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -149.97 0.74 9.68
Return on Assets - 5 Yr. Avg. -197.07 2.54 10.88
Return on Investment (TTM) -207.86 1.52 12.66
Return on Investment - 5 Yr. Avg. -320.23 2.08 14.01
Return on Equity (TTM) -- 0.25 14.84
Return on Equity - 5 Yr. Avg. -506.98 -1.25 15.40
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 11.01 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Bellerophon Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 34.87 33.39 99 95
13 Week -54.79 -56.59 8 72
26 Week -38.54 -42.28 38 44
52 Week 12.38 -2.74 99 88
YTD -54.26 -57.67 25 84
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 66.00%
# of Holders: 35
Total Shares Held: 38,147,173
3 Mo. Net Change: 2,745,520
# New Positions: 4
# Closed Positions: 5
# Increased Positions: 13
# Reduced Positions: 11
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.